EU authorises sale of vaccine against RSV in infants

The bloc-wide marketing authorisation of the jab, called Abrysvo and made by Pfizer, follows approval by the European drug watchdog, the European Medicines Agency (EMA) last month. The United States' Food and Drug Administration gave its own authorisation for the same vaccine for infants on Monday.